Dr. DeLuca's Addiction, Pain, and Public Health  Website

 

High-Frequency Users Of Gamma-Hydroxybutyric Acid At Highest Risk for Withdrawal Symptoms

By Anne MacLennan - 10/02/2001 - A review of the Am J Addict 2001;10:232-241 article: "Gamma-Hydroxybutyric Acid: Patterns of Use, Effects and Withdrawal"

 

High frequency users of gamma-hydroxybutyric acid are at greatest risk for withdrawal delirium and psychosis if use is stopped abruptly.

Gamma-hydroxybutyric acid (GHB) is an increasingly popular drug of abuse, and with its rise in use, reports of toxicity and lethality linked with it are also starting to accumulate.

Via a survey administered to 42 users of GHB, researchers sought to identify patterns of use of the drug as well as its effects and levels of abuse.

Overall, they found that the drug is used mainly to increase feelings of euphoria, relaxation and sexuality. Adverse effects related to its use tend to occur more frequently in people who are daily users and polydrug users than in those who use it occasionally.

However, 66 percent of the survey participants reported loss of consciousness during use of the drug, and 28 percent reported overdosing.

Furthermore, amnesia during GHB use was reported by 13 percent of participants and after use by 45 percent.

Three of the daily users in this study also developed a withdrawal syndrome that presented with anxiety, agitation, tremor and delirium.

Three daily GHB users in the study suggested intoxication with GHB is similar to that experienced with sedative-hypnotics or alcohol.

Regular use has also been shown to produce GHB tolerance and dependence, study authors note.

Indeed, study participants who were dependent on GHB reported using multiple daily doses and around the clock dosing.

It is these high-frequency users who appear to be at greatest risk for developing withdrawal delirium and psychosis after abrupt discontinuation of GHB use, study authors conclude.

[Am J Addict 2001;10:232-241 "Gamma-Hydroxybutyric Acid: Patterns of Use, Effects and Withdrawal"]

 


Alexander DeLuca, M.D., FASAM.
Copyright © 2001 All rights reserved.                            [Top of Page]
Revised: November 3rd, 2001.
Dr. DeLuca's Addiction, Pain, and Public Health Website